Detalhe da pesquisa
1.
A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder.
J Clin Psychopharmacol
; 37(3): 315-322, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28383364
2.
Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive-Compulsive and Impulsive Features in Adults with Binge Eating Disorder.
Eur Eat Disord Rev
; 24(3): 223-31, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26621156
3.
Efficacy and safety of mepolizumab administered subcutaneously for moderate to severe atopic dermatitis.
Allergy
; 75(4): 950-953, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31515809
4.
A generalized estimating equation approach to analysis of maintenance of wakefulness testing in a study of lisdexamfetamine dimesylate, armodafinil, and placebo in sleep-deprived adults.
J Clin Psychopharmacol
; 34(5): 642-4, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25180798
5.
Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
JAMA Psychiatry
; 74(9): 903-910, 2017 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28700805
6.
Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials.
Neuropsychopharmacology
; 41(5): 1251-60, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26346638
7.
Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
JAMA Psychiatry
; 72(3): 235-46, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25587645
8.
Participant-perceived quality of life in a long-term, open-label trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
J Child Adolesc Psychopharmacol
; 24(4): 210-7, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24815910
9.
A long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
J Child Adolesc Psychopharmacol
; 23(1): 11-21, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23410138
10.
Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.
J Clin Psychiatry
; 73(7): 977-83, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22780921
11.
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry
; 50(4): 395-405, 2011 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-21421179
12.
Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart.
J Cell Sci
; 115(Pt 8): 1623-34, 2002 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-11950881